As of 2026-03-29, 美国强生制药's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 7.9 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 美国强生制药's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
美国强生制药's Mention Rate is 0.00%, lower than 0.6% of competitors
美国强生制药's First Mention is 0.00%, lower than 0.9% of competitors
美国强生制药's Preferred Rate is 0.00%, lower than 100.0% of competitors
美国强生制药's Positive Rate is 0.00%, lower than 8.9% of competitors
美国强生制药's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 同同仁堂 | 28.57% | 0% | 0% | 8.16% | 24.49% | View Details |
| 恒恒瑞医药 | 16.33% | 2.04% | 7.14% | 16.33% | 0% | View Details |
| 云云南白药 | 12.24% | 0% | 0% | 12.24% | 0% | View Details |
| 修修正药业 | 10.2% | 0% | 0% | 2.04% | 8.16% | View Details |
| 石石药集团 | 4.08% | 0% | 0% | 4.08% | 0% | View Details |
| 广广药白云山 | 0% | 0% | 0% | 0% | 0% | View Details |
| 美美国强生制药 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
